These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8985412)

  • 1. Antibody prevents the establishment of persistent arenavirus infection in synergy with endogenous T cells.
    Baldridge JR; McGraw TS; Paoletti A; Buchmeier MJ
    J Virol; 1997 Jan; 71(1):755-8. PubMed ID: 8985412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: mother-to-baby transfer of humoral protection.
    Baldridge JR; Buchmeier MJ
    J Virol; 1992 Jul; 66(7):4252-7. PubMed ID: 1376367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.
    Matloubian M; Concepcion RJ; Ahmed R
    J Virol; 1994 Dec; 68(12):8056-63. PubMed ID: 7966595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal DNA immunization with a plasmid encoding an internal viral protein is effective in the presence of maternal antibodies and protects against subsequent viral challenge.
    Hassett DE; Zhang J; Whitton JL
    J Virol; 1997 Oct; 71(10):7881-8. PubMed ID: 9311877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of protective cytotoxic T cell responses in the presence of high titers of virus-neutralizing antibodies: implications for passive and active immunization.
    Seiler P; Bründler MA; Zimmermann C; Weibel D; Bruns M; Hengartner H; Zinkernagel RM
    J Exp Med; 1998 Feb; 187(4):649-54. PubMed ID: 9463415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence.
    Ahmed R; Salmi A; Butler LD; Chiller JM; Oldstone MB
    J Exp Med; 1984 Aug; 160(2):521-40. PubMed ID: 6332167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-neutralizing antibodies protect from chronic LCMV infection independently of activating FcγR or complement.
    Richter K; Oxenius A
    Eur J Immunol; 2013 Sep; 43(9):2349-60. PubMed ID: 23749374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleoprotein-specific nonneutralizing antibodies speed up LCMV elimination independently of complement and FcγR.
    Straub T; Schweier O; Bruns M; Nimmerjahn F; Waisman A; Pircher H
    Eur J Immunol; 2013 Sep; 43(9):2338-48. PubMed ID: 23749409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopathological basis of lymphocytic choriomeningitis virus-induced chorioretinitis and keratitis.
    Zinkernagel MS; Bolinger B; Krebs P; Onder L; Miller S; Ludewig B
    J Virol; 2009 Jan; 83(1):159-66. PubMed ID: 18945766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Resistance to Mousepox during Chronic Lymphocytic Choriomeningitis Virus Infection Is Associated with Impaired T-Cell Responses and Can Be Rescued by Immunization.
    Alves-Peixoto P; Férez M; Knudson CJ; Melo-Silva CR; Stotesbury C; Wong EB; Correia-Neves M; Sigal LJ
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31826990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers.
    Planz O; Ehl S; Furrer E; Horvath E; Bründler MA; Hengartner H; Zinkernagel RM
    Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6874-9. PubMed ID: 9192659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells in the brain enhance neonatal mortality during peripheral LCMV infection.
    Kenney LL; Carter EP; Gil A; Selin LK
    PLoS Pathog; 2021 Jan; 17(1):e1009066. PubMed ID: 33400715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus-specific, CD8+ major histocompatibility complex class I-restricted cytotoxic T lymphocytes in lymphocytic choriomeningitis virus-infected beta2-microglobulin-deficient mice.
    Quinn DG; Zajac AJ; Hioe CE; Frelinger JA
    J Virol; 1997 Nov; 71(11):8392-6. PubMed ID: 9343195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
    Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
    Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge.
    von Herrath MG; Yokoyama M; Dockter J; Oldstone MB; Whitton JL
    J Virol; 1996 Feb; 70(2):1072-9. PubMed ID: 8551565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of CD3 delta knockout mice from lymphocytic choriomeningitis virus-induced immunopathology: implications for viral neuroinvasion.
    Kappes DJ; Lawrence DM; Vaughn MM; Davé VP; Belman AR; Rall GF
    Virology; 2000 Apr; 269(2):248-56. PubMed ID: 10753703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of virus-specific antibody production by CD8+ class I-restricted antiviral cytotoxic T cells in vivo.
    Moskophidis D; Pircher H; Ciernik I; Odermatt B; Hengartner H; Zinkernagel RM
    J Virol; 1992 Jun; 66(6):3661-8. PubMed ID: 1583725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection.
    Klavinskis LS; Whitton JL; Oldstone MB
    J Virol; 1989 Oct; 63(10):4311-6. PubMed ID: 2476571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination against lymphocytic choriomeningitis virus infection in MHC class II-deficient mice.
    Holst PJ; Christensen JP; Thomsen AR
    J Immunol; 2011 Apr; 186(7):3997-4007. PubMed ID: 21357263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus.
    Moskophidis D; Zinkernagel RM
    J Virol; 1995 Apr; 69(4):2187-93. PubMed ID: 7533851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.